Literature DB >> 1463368

Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic noncholinergic nerves in the rat gastric fundus.

G E Boeckxstaens1, P A Pelckmans, J G De Man, H Bult, A G Herman, Y M Van Maercke.   

Abstract

The roles of vasoactive intestinal polypeptide (VIP) and nitric oxide (NO) in nonadrenergic noncholinergic (NANC) nerve-mediated relaxations were investigated in longitudinal muscle strips of the rat gastric fundus. Transmural stimulation (1-16 Hz for 2 min), VIP and noradrenaline evoked a prolonged relaxation of the rat gastric fundus, whereas NO evoked a transient relaxation. Only the electrically induced responses were blocked by tetrodotoxin. The inhibitor of NO biosynthesis NG-nitro-L-arginine (L-NNA) preferentially inhibited the relaxations induced by low frequency stimulation. In contrast, trypsin mainly reduced the electrically induced relaxations to high frequency stimulation; the NANC relaxations resistant to trypsin were further inhibited by L-NNA. VIP-induced relaxations were abolished by trypsin, but remained unaffected by L-NNA. NO- or noradrenaline-induced relaxations were not inhibited by either L-NNA or trypsin alone, whereas the combination of L-NNA and trypsin slightly reduced the noradrenaline-induced responses. These results suggest that NANC responses in the rat gastric fundus at low frequency are mediated mainly by NO, whereas at higher frequency NO together with a peptide, probably VIP, are released.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463368

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  36 in total

1.  Pre- and postjunctional protective effect of neocuproine on the nitrergic neurotransmitter in the mouse gastric fundus.

Authors:  J G De Man ; T G Moreels; B Y De Winter ; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Investigation of the interaction between nitric oxide and vasoactive intestinal polypeptide in the guinea-pig gastric fundus.

Authors:  J M Dick; L A Van Geldre; J P Timmermans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Participation of nitric oxide in the relaxation of the rat gastric corpus.

Authors:  U Holzer-Petsche; R L Moser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Nicotinic acetylcholine receptor blocking effect of guanethidine in the rat gastric fundus.

Authors:  P J Blommaart; G Ferwerda; A Kodde; G N Tytgat; G E Boeckxstaens
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

5.  Influence of S-nitrosothiols and nitrate tolerance in the rat gastric fundus.

Authors:  A J Barbier; R A Lefebvre
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

6.  Nitric oxide synthase activity and non-adrenergic non-cholinergic relaxation in the rat gastric fundus.

Authors:  D Currò; A R Volpe; P Preziosi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus.

Authors:  R A Lefebvre; G J Smits; J P Timmermans
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Functional role of vasoactive intestinal polypeptide in inhibitory motor innervation in the mouse internal anal sphincter.

Authors:  K D Keef; S N Saxton; R A McDowall; R E Kaminski; A M Duffy; C A Cobine
Journal:  J Physiol       Date:  2013-01-21       Impact factor: 5.182

9.  Distribution of NADPH diaphorase-positive neurons in the enteric nervous system of the rabbit intestine.

Authors:  C Junquera; C Martínez-Ciriano; J Blasco; J Aisa; M T Peg; M J Azanza
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

10.  Nitric oxide, an enteric nonadrenergic-noncholinergic relaxant transmitter: evidence using phosphodiesterase V and nitric oxide synthase inhibition.

Authors:  S J Williams; M E Parsons
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.